← Insider buys
EXEL

Exelixis, Inc. · Healthcare

Director Alan M Garber sold $461K of Exelixis, Inc.

Sold$461,112
$24.01Price
19,205Shares
−35%Stake

What EXEL did after the filing

Filed Mar 25Copier in Mar 26
The stock from Tue, Mar 26 open, $23.70
−8.9%
S&P 500, same days
−0.8%

Measured over 30 trading days, to the May 8 close.

Traded Thu, Mar 21. Filed Mon, Mar 25, 7:31 PM ET, after the close. Returns use the Mar 26 open and the May 8 close. Not investment advice.